Core Viewpoint - The article highlights significant developments in Chongqing, including administrative adjustments and initiatives to support the innovative pharmaceutical industry, which are expected to drive economic growth and enhance the city's development strategy [3][6][10]. Administrative Adjustments - On November 6, Chongqing announced administrative adjustments involving the establishment of the Liangjiang New Area, which will incorporate parts of Jiangbei District and Yubei District, aiming to optimize urban space and functions [6][7]. - The adjustments are designed to enhance the coordination between the Liangjiang New Area and surrounding districts, promoting integrated development and creating a core growth engine for the city [8][9]. Innovative Pharmaceutical Industry Initiatives - The Chongqing government released measures to support the high-quality development of innovative drugs, aiming to approve 1-3 new drugs annually by 2027 and establish a comprehensive innovation ecosystem [10][11]. - Financial incentives include funding support for various stages of drug development, with a maximum of 1 million yuan per project for late-stage clinical trials [10][11]. - The measures also emphasize the integration of artificial intelligence in drug development, aiming to create a comprehensive AI-driven pharmaceutical research system [12][13].